PureTech Health (PRTC) Invested Capital: 2019-2024

  • PureTech Health's Invested Capital was N/A to $306.8 million in Q2 2024 from the same period last year, while for Jun 2024 it was $306.8 million, marking a year-over-year change of. This contributed to the annual value of $391.7 million for FY2023, which is 39.30% down from last year.
  • According to the latest figures from Q2 2024, PureTech Health's Invested Capital is $306.8 million, which was down 21.68% from $391.7 million recorded in Q4 2023.
  • PureTech Health's Invested Capital's 5-year high stood at $684.6 million during Q4 2020, with a 5-year trough of -$45.4 million in Q4 2021.
  • Over the past 3 years, PureTech Health's median Invested Capital value was $391.7 million (recorded in 2023), while the average stood at $447.9 million.
  • In the last 5 years, PureTech Health's Invested Capital plummeted by 106.64% in 2021 and then skyrocketed by 1,520.17% in 2022.
  • PureTech Health's Invested Capital (Quarterly) stood at $684.6 million in 2020, then plummeted by 106.64% to -$45.4 million in 2021, then surged by 1,520.17% to $645.3 million in 2022, then tumbled by 39.30% to $391.7 million in 2023, then reached $306.8 million in 2024.
  • Its Invested Capital was $306.8 million in Q2 2024, compared to $391.7 million in Q4 2023 and $645.3 million in Q4 2022.